Annotation Detail

Information
Associated Genes
CTLA4
Associated Variants
CTLA4 UNKNOWN
Source Database
MMMP
Description
In this phase I-II trial, a 39% disease control rate was achieved in patients with metastatic melanoma
MMMP State
uncharacterized
MMMP Molecule
CTLA4
MMMP Relationship
sensitivity to
MMMP Drug
Ipilimumab
MMMP Drug Alias
CTLA4 antibody (antagonist)
MMMP Model
5
MMMP Reference
Weber JS, J Clin Oncol 2008, 26:5950-6
Drugs
Drug NameSensitivitySupported
IpilimumabSensitivitytrue